Transfusion-Transmissible Diseases: Further Reading

Note: Canadian Blood Services offers no endorsement of and assumes no liability for the currency, accuracy, or availability of any information on these sites.

1. Blajchman MA, Goldman M, Freedman JJ, Sher GD. Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction. Transfus Med Rev. 2001 Jan.;15(1):1-20.
2. Blajchman MA, Goldman M, Webert KE, Vamvakas EC, Hannon J, Delage G, Proceedings of a consensus conference: the screening of blood donors for variant CJD. Transfus Med Rev. 2004 Apr; 18(2): 73-92.
3. Busch MP, Kleinman SH, Nemo GJ, Current and emerging infectious risks of blood transfusions. JAMA 2003; 289: 959-62.
4. Callum JL, Coovadia AS, Thomson A, Dewsbury F, Pinkerton PH. Creutzfeldt-Jakob disease targeted lookback. Transfusion 1999 May;39(5):540-1. [ Full text ] [ Medline ]
5. Chiavetta JA, Escobar M, Newman A, HE Y, Driezen P, Deeks S, Hone DE, O’Brien SF, Sher G. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ. 2003 Oct 14; 169(8): 767-73.
6. Dodd RY, Notari EP IV, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42: 975-9.
7. Gregori L, McCombie N, Palmer D, Birch P, Sowemimo-Coker SO, Giulivi A, Rohwer RG. Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet. 2004 Aug 7:364(9433): 529-31. [Medline]
8. Hart J, Leier B, Nahirniak S. Informed consent for blood transfusion: should the possibility of prion risk be included? Transfus Med Rev. 2004 Jul; 18(3): 177-83. [Medline]
9. Kleinman C, Chan P, Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 2003 Apr.;17(2):120-62.
10. Laupacis A, Brown J, Costello B, Delage G, Freedman J, Hume H, et al. Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement. Transfusion. 2001 Apr.;41(4):560-9. [ Full text ] [ Medline ]
11. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG. Possible transmission of variant Creutzfeldt-jakob disease by blood transfusion. Lancet. 2004 Feb 7:363 (9407):417-21. [Medline]
12. McCullough J, Anderson D, Brookie D, Bouchard JP, Fergusson D, Joly J, Kenny N, Lee D, Megann H, Page D, Reinharz D, Williams JR, Wilson K, Consensus conference on vCJD screening of blood donors: report of the panel. Transfusion. 2004 May; 44(5): 675-83.
13. Orton SL, Stramer SL, Dodd, RY, Alter, MJ. Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCB RNA and not reactive for the presence of anti-HCV. Transfusion 2004; 44: 275-81.
14. Pealer LN, Martin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J. Med 2003; 349: 1236-45.
15. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet. 2004 Aug 7; 364(9433): 527-9. [Medline]
16. Pincock S. Government confirms second case of vCJD transmitted by blood transfusion. BMJ. 2004 Jul 31; 329(7460): 251. [Medline]
17. Preiksaitis JB. The cytomegalovirus - "safe" blood product: Is leukoreduction equivalent to antibody screening? Transfus Med Rev 2000;14:112-36. [ Medline ]
18. Regan FAM, Hewitt P, John A J Barbara JAJ, Contreras M. Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. Br Med J 2000;320: 403-6.
19. Stramer, SL, Glynn, SA, Kleinman, SH, Strong, DM, Caglioti, S., Wright, DJ, Dodd, RY, Busch, MP. Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid-Amplification Testing. N Engl J Med. 2004, August: 760-768.
20. Update: West Nile virus screening of blood donations and transfusion-associated transmission-United States, 2003. MMWR Morb Mortal Wkly Rep 2004, 53: 281-4.
21. Wilson K, Ricketts MN. Transfusion transmission of vCJD: a crisis avoided? Lancet. 2004 Aug 7; 364 (9433): 477-9. [Medline]
22. Zou S, Notari EP, Stramis SL, Wahab, F, Musaui F, Dodd RY. For the ARCNET Reseach Group. Patterns of age-and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion 2004 November; 44(11): 1640-47. [Medline]